Pharmalot: By Ed Silverman // February 1st, 2013
After 15 months of delay, the Centers for Medicare & Medicaid Services has finally released the long-awaited Sunshine Act rule, which establishes procedures for gathering and publishing data containing financial ties between physicians, teaching hospitals and drug and device makers, as well as group purchasing organizations.
The rule was created to address rising concerns that such financial relationships may unduly influence medical research and practice. For this reason, the release of the final versions marks a watershed moment in the ongoing effort by a wide array of organizations and individuals to force drug and device makers to become more transparent. Even small financial ties have been shown in studies to bias physicians Read more